Delivery Order 75F40121D00018-75F40122F19002
Award Date 6/15/22
Potential Completion Date 9/30/22
Potential Value $146K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $169,918.01 firm fixed price delivery order contract to We Pharma, Inc. of Morrisville, North Carolina. The purpose of this requirement is to obtain currently marketed drug products for FDA research studies. We Pharma will provide the requested products to the FDA under this contract, which has a completion date of September 29, 2021. No set-aside designation was used for this award made on September 30, 2020.
- This delivery order against the Department of Health and Human Services Food and Drug Administration is for the purpose of obtaining currently marketed drug products for FDA research studies. Awarded on September 30, 2020 to We Pharma, Inc. located in Morrisville, North Carolina, this firm fixed price contract has a potential value of $246,754.22 and period of performance through September 29, 2021. No set-aside designation was applied. We Pharma Inc. will provide the requested drug products...
- The Food and Drug Administration (FDA) awarded a delivery order valued at $300,000 to We Pharma, Inc., doing business as WEP Clinical, for the provision of pharmaceutical drug products to support FDA research studies. The contract, which is firm fixed price with no set-aside designation, carries an ultimate completion date of September 16, 2026, and will be performed at the FDA's Takoma Park, Maryland location. We Pharma, a self-certified small disadvantaged business and limited liability...
- This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services, to We Pharma, Inc., a self-certified small disadvantaged business. The $214,914.90 contract is for the provision of "PHYSICOCHEMICAL PRODUCTS" and has a total small business set-aside. The award supports the FDA's regulatory science program and provides pharmaceutical drug products for the agency's research, compliance, and...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $22,805.26 delivery order contract to Premier & Companies, Inc. under the Multiple Award Schedule (MAS) vehicle. The contract is for CDER OBI DOCUMENT ROOM OFFICE SUPPLIES and will be performed in Silver Spring, Maryland through September 2024. The contract has a firm fixed price and is set aside for total small businesses. Premier & Companies, Inc. will provide office supplies to support the HHS...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $35,751.68 firm-fixed-price purchase order to Team Results USA LLC. This purchase order is for a one-year masterclass team simulation to be delivered in Silver Spring, Maryland from September 2023 through September 2024. As the regulatory agency responsible for protecting public health through ensuring the safety and effectiveness of human and veterinary drugs, medical devices, and other products, this...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) has awarded a $45,585.12 firm-fixed-price delivery order to Watch House International LLC, a security, safety, training, and investigative services provider, to provide training in personal safety for FDA personnel conducting inspections and enforcement activities under the Basic Food, Drug, and Cosmetic Act and related regulations. This delivery order was not set aside for any socioeconomic program. Watch House...
- The Department of Health and Human Services Food and Drug Administration awarded a $289,916 delivery order contract to Midnight Sun Technologies LLC Virginia Branch Division for Scientist IV services. As a subsidiary of Kikiktagruk Inupiat Corp, Midnight Sun will provide the Scientist IV under a time and materials contract running from August 2020 through April 2022. The work will be performed in Silver Spring, Maryland and supports the FDA's regulatory science programs. No subcontractors or set...
- The Department of Health and Human Services Food and Drug Administration awarded a $4.8 million firm fixed price delivery order to Dun & Bradstreet Inc., doing business as D&B, for core services. The one-year contract will provide products and services to support HHS/FDA programs from D&B's offices in Herndon, Virginia. As one of the largest federal civilian agencies, HHS/FDA relies on data and analytical tools from major database and research firms under the Solutions for...
- <p>The Food and Drug Administration awarded a purchase order to Honeywell International, Inc. valued at $20,195.93 on June 15, 2026, for repair of loading dock doors at Laboratory Building 52, FDA White Oak in Silver Spring, Maryland. The order carries a firm fixed price and is scheduled for completion by January 12, 2027. No set-aside was applied. Work is performed in Silver Spring, Maryland.</p>
- 75F40121D00018Indefinite Delivery Contract
- 75F40121D00018-75F40122F19002Delivery Order
The Department of Health and Human Services Food and Drug Administration awarded a $145,636.17 firm fixed price delivery order to We Pharma, Inc. of Silver Spring, Maryland for pharmaceutical products to support domestic manufacturing. No set-aside provisions were applied to this contract. We Pharma will provide the FDA's Office of Pharmaceutical Quality with domestic pharmaceutical manufacturing supplies through September 30th, 2022 at their Silver Spring location. As the regulatory body responsible for ensuring drug safety, effectiveness and quality in the United States, this delivery order will enable the FDA to carry out important public health functions through 2022.
Generated 1/3/24, 11:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($4k) | 3/30/23 | |
| Not listed | Not listed | $150.0k | 6/15/22 |